What is a Clinical Trial?
Clinical trials are voluntary
research studies conducted in people and designed to answer specific questions
about the safety or effectiveness of drugs, vaccines, other therapies, or new
ways of using existing treatments.
Clinical research is
studies in which people participate as patients or healthy volunteers. The idea
for a clinical research study often starts as a clinical trial in the
laboratory. The main two types of
clinical research are called Observational Studies (also known as
Non-Interventional Studies) and Clinical Trials (also known as Interventional
Studies).
Non-Interventional
or Observational Studies: Non-interventional studies are often known as observational
studies. Observational studies occur when research is focused on identifying or
analyzing changes that occur over time through monitoring habits, medical data,
and biological samples. Observational
studies do not test medical interventions, like a drug or device, but may help
identify treatment or prevention strategies.
Interventional Studies or
Clinical Trials: Interventional studies are often known as clinical trials. Clinical
trials are research studies that test the safety and effectiveness of medical,
surgical, or behavioral intervention in people. They require people of every
age, health status, race, gender, ethnicity, and cultural background to
participate. Both healthy and those with diagnosed medical conditions can take
part in clinical trials.
Learn more about different types of clinical research here:
Find Clinical Research Opportunities in Nevada
Interested in participating in a clinical research opportunity? Checkout a few Nevadan organizations that conduct clinical research below.
National Clinical Research Opportunities
- The All of Us Research Program funded through the National Institutes of Health is working to improve health care through research. Unlike research studies that focus on one disease, All of Us is building a diverse database that can inform thousands of studies.
Clinicaltrials.gov
is a registry and results database. Use the following tips to
navigate the website to learn more about research opportunities available in
Nevada. of publicly and privately supported clinical studies of human
participants conducted around the world. This website not only shows open
studies, but all clinical trials that have been conducted. Use the following
tips to navigate the website to learn more about research opportunities
available in Nevada.
- Type in the
condition or disease you want to learn more about. (Ex: Alzheimer’s, Heart
Attack)
- If you have
additional search criteria you would like to search, type in under “Other
Terms”. (Ex: “heart attack” treatment)
- If you would like
to learn about a specific kind of intervention/ treatment, type the treatment
under “Intervention/treatment” (Ex: Aspirin, Exercise)
- If you want to see all trials done in Nevada (even those that have concluded), type Nevada or a city or address under "Location"
Assembly Bill 214
During the 79th (2017) session of the Nevada
Legislature, Assembly Bill (AB) 214 was passed. This bill requires the
Division of Public and Behavioral Health (DPBH) to establish a program to
encourage participation in clinical trials of drugs and medical devices by
persons who are members of demographic groups that are underrepresented in such
trials. This bill also requires each state or local governmental entity that
conducts such trials to adopt a policy concerning the identification and
recruitment of such persons to participate in those trials.
Diversity in Clinical Trials
Health and wellness is
shaped by our physical and mental well-being. Our physical and mental wellbeing
is influenced and defined by our biology, behavior, environment, society,
social policies, and lived experiences. The lived experiences of people vary based on
many factors like race, age, socioeconomic status, sexual orientation, gender
identity, geographic location and more. Simply
put, we are all different in many ways and similar in others. It is this
diversity that clinical researchers should consider and include when creating,
modifying, and studying medical initiatives, interventions, and therapeutics.
Diseases, disorders, therapeutics,
and medications affect different populations differently. Historically,
clinical trials often did not recruit participants who represented the
individuals most affected by a particular condition. Rather, clinical research
relied almost exclusively on white male study participants leading to gaps in
understanding of diseases, conditions, preventative factors, and treatment
effectiveness. In addition to this, historical atrocities and incidents have led
to many communities developing and maintaining mistrust in clinical research
and medical institutions.
This clinical research
history has led to gaps in knowledge that impede comprehensive public health
and medical understanding of medical conditions, preventative measures, and
treatment effectiveness. As a result,
many initiatives and policies have been established to reduce inequities,
discrimination, and mistrust while increasing accountability and diverse involvement.
This is reflected in
the following national policies:
- 1974 National Research Act
- On July 12, 1974, the
National Research Act (Pub. L. 93-348) was signed into law, thereby creating
the National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research.
- The Belmont Report created by the
National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research
- A report that
establishes the basic ethical principles that should underlie the conduct of
biomedical and behavioral research involving human subjects and to develop
guidelines which should be followed to assure that such research is conducted
in accordance with those principles.
- Establishment of Institutional
Review Boards (IRB) by the National Research Act
- Institutional Review Boards,
also known as IRB, are groups that have been formally designated to review and
monitor research involving human subjects. The purpose of IRB review is to
assure that appropriate steps are taken to protect the rights and welfare of
humans participating as subjects in the research.
- 1993 NIH Revitalization Act
- The NIH Revitalization
Act of 1993, PL 103-43 (Public Health Service Act sec. 492B, 42 U.S.C. sec.
289a-2), signed into law on June 10, 1993, directed the NIH to establish
guidelines for inclusion of women and minorities in clinical research The
statute requires NIH to ensure that clinical trials are carried out in a manner
sufficient to provide for a valid analysis of whether the variables being
studied affect women or members of minority groups differently than other trial
participants.
- 21st Century Cures Act
- The 21st Century Cures Act, PL 114-255,
enacted December 13, 2016, requires entities conducting applicable clinical
trials submit results of valid analyses by sex/gender, race, and ethnicity in
Clinicaltrials.gov. The statute further requires that NIH consider, as
appropriate, whether the entity has complied with this reporting requirement
when awarding any future grant to that entity; and that NIH encourage the
reporting of the results of valid analysis through any additional means
determined appropriate.
- 2024 Revisions to the Statistical
Policy Directive No.15: Standards for Maintaining, Collecting, and Presenting
Federal Data on Race and Ethnicity
- In March 2024, the
U.S. Office of Management and Budget (OMB) published a set of revisions to the
Statistical Policy Directive (SPD) No. 15: Standards for Maintaining,
Collecting, and Presenting Federal Data on Race and Ethnicity providing
significant changes to data collections established and utilized since 1997.
The revisions incorporated culturally mindful practices and changes to the
standardized language established nationally.
Within the state of Nevada,
it is also acknowledged that it is only when the populations included in
clinical research are fully reflective of the diversity of the country can we
ensure that public health and medical interventions are mindful of
manifestation differences. As such, Assembly Bill 214 was established to
encourage the intentional diversification of clinical research within Nevada. To learn more about why it is important to
diversify clinical research, please visit the websites linked below.
Resources for Nevadans Interested in Learning More about Clinical Research Opportunities
Interested in learning more about clinical research and opportunities available? Check out the resources linked below.
Resources for Researchers in Nevada
There are many organizations conducting clinical research within the State of Nevada. This section of the webpage is designed to provide researchers with resources that will aid in being culturally aware, responsive, sensitive, and literate. The State of Nevada is full of diversity. This diversity includes geographic location, socioeconomic status, race, ethnicity, age, language and more.
The following resources take these factors into account.